News
NOVEMBER 20, 2024
Paul Hastings Advised TD Securities in Forte Biosciences’ Oversubscribed Private Placement
Read Time: 1 min
Paul Hastings LLP advised TD Securities (USA) LLC as lead placement agent in connection with Forte Biosciences, Inc.’s (NASDAQ: FBRX) oversubscribed $53 million PIPE financing.
The Paul Hastings team included Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and partner Will Magioncalda.
More details can be found here.
With widely recognized elite teams across 18 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world's leading investment banks, asset managers and corporations.